Recent studies looked at biomarkers to predict diabetes, characteristics of patients who developed type 1 diabetes during adulthood, and use of oral insulin to try to prevent type 1 diabetes.
Recent studies looked at vitamin D supplementation, peer mentoring, and physician referrals to diabetes prevention programs among patients with prediabetes.
Recent industry-funded studies compared degludec, an ultralong-acting, once-daily basal insulin, to basal insulin glargine on outcomes including hypoglycemia, glucose control, and cardiovascular events.
Data from the Diabetes Prevention Program (DPP) Outcomes Study showed little effect of diabetes prevention efforts on patients' cognition or coronary artery calcium, according two recent studies.
From the ancient Egyptians to current pilot projects, two recent articles in the New England Journal of Medicine reviewed the history and current state of diabetes care.
Recent trials examined the potential effects of probiotic supplements and sucrose octasulfate dressings.
Studies published in the past month looked at statin prescriptions for patients with diabetes and osteoporotic fracture risk in women with diabetes.
Evidence on possible risks of pioglitazone, including bladder cancer, prostate cancer, and fractures, made the news in the past month.
Two recent studies found associations between economic factors and diabetes incidence and control.
The American Diabetes Association (ADA) issued a new position statement on physical activity and exercise, and a recent study offered some additional advice on the topic.